Holen Sie sich die Stockscreener-App
90.20
2.13%
-1.96
Handel nachbörslich:
92.90
2.70
+2.99%
Oruka Therapeutics Inc Aktie (ORKA) Neueste Nachrichten
Oruka Therapeutics Inc (ORKA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Oruka Therapeutics Inc (ORKA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Oruka Therapeutics Inc (ORKA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ORKA|Oruka Therapeutics Inc|Price:92.160|Chg%:+0.210 - TradingKey
TradingKey - TradingKey
Oruka Therapeutics Inc (ORKA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Oruka Therapeutics, Inc. Revenue Breakdown – NASDAQ:ORKA - TradingView
ORKA Stock Is Soaring After Psoriasis Trial Results — Here's Why BTIG Hiked Its Price Target By 94% - Stocktwits
Oruka Therapeutics Inc (ORKA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Oruka Therapeutics Inc. (ORKA) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
ORKA Stock Climbs As Traders Track Tight Range - StocksToTrade
ORKA Stock Grinds Higher As Traders Track Tight Range - timothysykes.com
ORKA Stock Climbs As Traders Track Strong Cash Runway - StocksToTrade
Oruka Therapeutics Rises as Investors Focus on Pipeline Data Setup - Quiver Quantitative
Form 144 ORUKA THERAPEUTICS INC For: 15 July By Investing.com - Investing.com Australia
Oruka Therapeutics CMO Joana Goncalves sells $603,937 in shares - Investing.com UK
Form 4 Oruka Therapeutics Inc For: 15 July By Investing.com - Investing.com Nigeria
Oruka Therapeutics CMO Joana Goncalves sells $603,937 in shares By Investing.com - Investing.com Nigeria
Form 4 Oruka Therapeutics Inc For: 15 July - Investing.com UK
Form 144 ORUKA THERAPEUTICS INC For: 15 July - Investing.com UK
BTIG Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $151 - Moomoo
Form 4 Oruka Therapeutics Inc For: 13 July By Investing.com - Investing.com South Africa
Oruka Therapeutics SVP sells $846k in stock By Investing.com - Investing.com Nigeria
Form 144 Oruka Therapeutics For: 13 July By Investing.com - Investing.com Australia
Oruka Therapeutics Insider Sold Shares Worth $846,180, According to a Recent SEC Filing - Moomoo
Oruka Therapeutics SVP sells $846k in stock - Investing.com
Form 144 Oruka Therapeutics For: 13 July - Investing.com UK
Oruka TherapeuticsIntriguing Long Acting Psoriasis Programs May Need Further Derisking - Seeking Alpha
How Investors May Respond To Oruka Therapeutics (ORKA) Russell Index Shift Toward Small-Cap Growth Benchmarks - simplywall.st
Oruka Therapeutics Shares Drop After Hours After Fairmount Unloads 3.55 Million Shares - MSN
Oruka Therapeutics (ORKA) Holds Steady Near Resistance Amid Low VolatilityOption Breadth - dars.gov.et
Oruka Therapeutics (ORKA) Recast By Russell Growth Shift On A Valuation That Looks About Right - Sahm
Why Oruka Therapeutics (ORKA) Is Up 13.6% After Russell Index Reclassification Into Growth Benchmarks - Sahm
UBS Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $130 - Moomoo
Oruka Therapeutics (ORKA) Sees 8.1% Decline - GuruFocus
Oruka Therapeutics Insider Sold Shares Worth $472,079, According to a Recent SEC Filing - marketscreener.com
Fairmount Healthcare Fund II sells $300m Oruka Therapeutics stock By Investing.com - Investing.com India
Form 144 | Oruka Therapeutics(ORKA.US) Insider Proposes to Sell 300.01 Million in Common Stocks - Moomoo
Insider Sell: Laura Sandler Sells 5,000 Shares of Oruka Therapeu - GuruFocus
Form 144 Oruka Therapeutics For: 1 July By Investing.com - Investing.com Nigeria
Form 13D/A ORUKA THERAPEUTICS For: 1 July By Investing.com - Investing.com Nigeria
Fairmount Healthcare Fund II sells $300m Oruka Therapeutics stock - Investing.com
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):